Korean journal of dermatology (대한피부과학회지)

Korean Dermatological Association (대한피부과학회)
권호 표지

Anti-inflammatory Effect of Curcumin on UVB-induced Inflammatory Cytokines in HaCaT Cells

HaCaT 각질형성세포에서 자외선 B에 의하여 유도되는 염증성 사이토카인에 대한 Curcumin의 항염증 효과

Cho, Jae-We;Lee, Kyu-Suk
조재위;이규석

  • Published : 20090200
⟨ Previous Next ⟩

Abstract

Background: UVB irradiation induces acute inflammation through expressions of IL-6, IL-8, and TNF-$\alpha$, in keratinocytes. Curcumin, extracted from the rhizomes of Curcuma longa, has been described as having anti-inflammatory properties; however, it still unknown as to whether curcumin inhibits the UVB-induced expressions of IL-6, IL-8, and TNF-$\alpha$ in HaCaT cell lines. Objective: In this study we investigated the effects of curcumin on the expression of IL-6, IL-8, and TNF-$\alpha$ in HaCaT cells, as well as the photoprotective effect of curcumin ointment in UVB-irradiated hair less mice. Methods: HaCaT cells were irradiated with various doses of UVB (0, 100, 200, 300 mJ/$cm^2$). Total RNA was extracted from the cells and gene expression was confirmed by RT-PCR, EMSA, and Western blot analysis. In addition we examined whether the ointment containing curcumin prevents the photo damaging events in hairless mice. Results: UVB-irradiated HaCaT cells clearly showed an increased expression of IL-6, IL-8, and TNF-$\alpha$ in a UVB dose-dependent manner (0, 100, 200, 300 mJ/$cm^2$). Interestingly, pretreatment of curcumin (40 uM) dramatically reduced the expressions of UVB-induced IL-6, IL-8, and TNF-$\alpha$. In addition, activation of NF-$\kappa$B and MAPKs (p38, JNK, ERK) by UVB were partially attenuated by pretreatment of curcumin in HaCaT cells. Furthermore, the application of ointment containing curcumin partially protected the erythema and skin atrophy in UVB-irradiated hairless nude mice. Conclusion: Collectively, these results indicate that curcumin may be applied as a promising anti-inflammatory natural agent through modulation of inflammatory cytokines such as IL-6, IL-8, and TNF-$\alpha$.

Keywords

References

  1. Granstein RD, Matsui MS. UV radiation-induced immunosuppression and skin cancer. Cutis 2004;74:4-9
  2. Heck DE, Gerecke DR, Vetrano AM, Laskin JD. Solar ultraviolet radiation as a trigger of cell signal transduction. Toxicol Appl Pharmacol 2004;195:288-297 https://doi.org/10.1016/j.taap.2003.09.028
  3. Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 2004;195:298-308 https://doi.org/10.1016/j.taap.2003.08.019
  4. Ambach W, Blumthaler M. Biological effectiveness of solar UV radiation in humans. Experientia 1993;49:747-753 https://doi.org/10.1007/BF01923543
  5. Afaq F, Mukhtar H. Photochemoprevention by botanical antioxidants. Skin Pharmacol Appl Skin Physiol 2002;15:297-306 https://doi.org/10.1159/000064533
  6. Afaq F, Adhami VM, Mukhtar H. Photochemoprevention of ultraviolet B signaling and photocarcinogenesis. Mutat Res 2005;571:153-173 https://doi.org/10.1016/j.mrfmmm.2004.07.019
  7. Grundmann JU, Bockelmann R, Bonnekoh B, Gollnick HP. UV erythema reducing capacity of mizolastine compared to acetylsalicylic acid or both combined in comparison to indomethacin. Photochem Photobiol 2001;74:587-592 https://doi.org/10.1562/0031-8655(2001)074<0587:UERCOM>2.0.CO;2
  8. Katiyar SK, Matsui MS, Elmets CA, Mukhtar H. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol 1999;69:148-153
  9. Matz H. UV light and its interaction with cutaneous receptors. Dermatol Clin 2007;25:633-641 https://doi.org/10.1016/j.det.2007.06.006
  10. Strickland FM, Kuchel JM, Halliday GM. Natural products as aids for protecting the skin's immune system against UV damage. Cutis 2004;74:24-28
  11. Mague JT, Alworth WL, Payton FL. Curcumin and deri vatives. Acta Crystallogr C 2004;60:608-610 https://doi.org/10.1107/S0108270104015434
  12. Chen HW, Huang HC. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol 1998;124:1029-1040 https://doi.org/10.1038/sj.bjp.0701914
  13. Odot J, Albert P, Carlier A, Tarpin M, Devy J, Madoulet C. In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int J Cancer 2004;111:381-387 https://doi.org/10.1002/ijc.20160
  14. Huang HC, Jan TR, Yeh SF. Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 1992;221:381-384 https://doi.org/10.1016/0014-2999(92)90727-L
  15. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23:363-398
  16. Hsu CH, Cheng AL. Clinical studies with curcumin. Adv Exp Med Biol 2007;595:471-480 https://doi.org/10.1007/978-0-387-46401-5_21
  17. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as 'Curecumin': from kitchen to clinic. Biochem Pharmacol 2008;75:787-80 https://doi.org/10.1016/j.bcp.2007.08.016
  18. Foryst-Ludwig A, Neumann M, Schneider-Brachert W, Naumann M. Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Commun 2004;316:1065-1072 https://doi.org/10.1016/j.bbrc.2004.02.158
  19. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008;65:1631-1652 https://doi.org/10.1007/s00018-008-7452-4
  20. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, Verleden GM. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells. Respir Med 2003;97:811-817 https://doi.org/10.1016/S0954-6111(03)00036-2
  21. Gautam SC, Gao X, Dulchavsky S. Immunomodulation by curcumin. Adv Exp Med Biol 2007;595:321-341 https://doi.org/10.1007/978-0-387-46401-5_14
  22. Shishodia S, Singh T, Chaturvedi MM. Modulation of transcription factors by curcumin. Adv Exp Med Biol 2007;595:127-148 https://doi.org/10.1007/978-0-387-46401-5_4
  23. Cho JW, Lee KS, Kim CW. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med 2007;19:469-474
  24. Thangapazham RL, Sharma A, Maheshwari RK. Beneficial role of curcumin in skin diseases. Adv Exp Med Biol 2007;595:343-357 https://doi.org/10.1007/978-0-387-46401-5_15
  25. Kurd SK, Smith N, VanVoorhees A, Troxel AB, Badmaev V, Seykora JT, et al. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial. J Am Acad Dermatol 2008;58:625-631 https://doi.org/10.1016/j.jaad.2007.12.035
  26. Pari L, Tewas D, Eckel J. Role of curcumin in health and disease. Arch Physiol Biochem 2008;114:127-149 https://doi.org/10.1080/13813450802033958
  27. Kuttan R, Sudheeran PC, Josph CD. Turmeric and curcumin as topical agents in cancer therapy. Tumori 1987;73:29-31 https://doi.org/10.1177/030089168707300105
  28. Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, et al. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 2002;95:1206-1214 https://doi.org/10.1002/cncr.10812
  29. Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 1978;43:86-92 https://doi.org/10.1111/j.1600-0773.1978.tb02240.x
  30. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999;27:486-494